Kinsie E. Arnst

Statistics

Publications

Citations

508

H-Index

Active since

2017

Affiliations

University of Tennessee Health Science Center(Current)

Sichuan University

St. Jude Children's Research Hospital

West China Hospital of Sichuan University

St. John's University

Kinsie E. Arnst is an author at University of Tennessee Health Science Center specializing in microtubule-targeting agents, microtubule-associated proteins, and pharmacology.

ORCID

Publications per year

2017–2021

Publications

A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance

Kinsie E. Arnst, Yuxi Wang, Dong‐Jin Hwang et al. · Cancer Research · 2017 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy

Souvik Banerjee, Kinsie E. Arnst, Yuxi Wang et al. · Journal of Medicinal Chemistry · 2018 · 107 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1<i>H</i>-Indol-3-yl)-1<i>H</i>-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin

Qinghui Wang, Kinsie E. Arnst, Yuxi Wang et al. · Journal of Medicinal Chemistry · 2019 · 82 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities

Qinghui Wang, Kinsie E. Arnst, Yuxi Wang et al. · Journal of Medicinal Chemistry · 2018 · 63 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16

Synthesis and biological evaluation of indole-based UC-112 analogs as potent and selective survivin inhibitors

Qinghui Wang, Kinsie E. Arnst, Yi Xue et al. · European Journal of Medicinal Chemistry · 2018 · 38 citations

Pharmacy, Medicinal Chemistry, Oncology +14

1–5 of 10